BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15077905)

  • 1. Somatostatin receptors and regulation of cell proliferation.
    Bousquet C; Guillermet J; Vernejoul F; Lahlou H; Buscail L; Susini C
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S2-7. PubMed ID: 15077905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiology of somatostatin receptors.
    Guillermet-Guibert J; Lahlou H; Cordelier P; Bousquet C; Pyronnet S; Susini C
    J Endocrinol Invest; 2005; 28(11 Suppl International):5-9. PubMed ID: 16625838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
    Guillermet-Guibert J; Lahlou H; Pyronnet S; Bousquet C; Susini C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):535-51. PubMed ID: 16183526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptors.
    Benali N; Ferjoux G; Puente E; Buscail L; Susini C
    Digestion; 2000; 62 Suppl 1():27-32. PubMed ID: 10940684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular signaling of somatostatin receptors.
    Lahlou H; Guillermet J; Hortala M; Vernejoul F; Pyronnet S; Bousquet C; Susini C
    Ann N Y Acad Sci; 2004 Apr; 1014():121-31. PubMed ID: 15153426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction of somatostatin receptors negatively controlling cell proliferation.
    Ferjoux G; Bousquet C; Cordelier P; Benali N; Lopez F; Rochaix P; Buscail L; Susini C
    J Physiol Paris; 2000; 94(3-4):205-10. PubMed ID: 11087998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease.
    Höcker M; Wiedenmann B
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S139-42. PubMed ID: 10604118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.
    Reubi JC; Waser B; Schaer JC; Laissue JA
    Eur J Nucl Med; 2001 Jul; 28(7):836-46. PubMed ID: 11504080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects.
    Park S; Kamegai J; Kineman RD
    Neuroendocrinology; 2003 Sep; 78(3):163-75. PubMed ID: 14512709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophs.
    Cervia D; Fehlmann D; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):578-87. PubMed ID: 12750875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology.
    Córdoba-Chacón J; Gahete MD; Durán-Prado M; Luque RM; Castaño JP
    Ann N Y Acad Sci; 2011 Mar; 1220():6-15. PubMed ID: 21388399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug design at peptide receptors: somatostatin receptor ligands.
    Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
    J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.
    Spary EJ; Maqbool A; Batten TF
    J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors and effects of the inhibitory neuropeptide somatostatin in microglial cells.
    Feindt J; Schmidt A; Mentlein R
    Brain Res Mol Brain Res; 1998 Oct; 60(2):228-33. PubMed ID: 9757047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical use of somatostatin analogues in the treatment of cancer.
    Lamberts SW; Krenning EP; Klijn JG; Reubi JC
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):29-49. PubMed ID: 1975166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptors in the thymus.
    Ferone D; van Hagen PM; Colao A; Annunziato L; Lamberts SW; Hofland LJ
    Ann Med; 1999 Oct; 31 Suppl 2():28-33. PubMed ID: 10574152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pharmacology of somatostatin receptors.
    Hoyer D; Lübbert H; Bruns C
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):441-53. PubMed ID: 7870182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum.
    Zaki M; Harrington L; McCuen R; Coy DH; Arimura A; Schubert ML
    Gastroenterology; 1996 Oct; 111(4):919-24. PubMed ID: 8831586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA.
    Luque RM; Park S; Peng XD; Delgado E; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2004 Apr; 32(2):437-48. PubMed ID: 15072550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New medical treatments in pituitary adenomas].
    Drutel A; Caron P; Archambeaud F
    Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.